Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 8931-230
Fax: +49 (0)711 - 8931-323
send an Email


Angiogenesis in metabolic-vascular disease

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Issue: 2017: Issue 7 2017 (pp. 1217-1454)
Pages: 1289-1295
Ahead of Print: 2017-06-08

Angiogenesis in metabolic-vascular disease

G. Breier (1), T. Chavakis (2), E. Hirsch (3)

(1) Division of Medical Biology, Department of Psychiatry, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Germany; (2) Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Germany; (3) Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy


diabetes, obesity, angiogenesis, metabolism, insulin resistance, glycolysis, PI3-kinase


Angiogenesis, literally formation of new blood vessels, is the main process through which the vascular system expands during embryonic and postnatal development. Endothelial cells, which constitute the inner lining of all blood vessels, are typically in a quiescent state in the healthy adult organism. However, in vascular and metabolic diseases, the endothelium becomes unstable and dysfunctional. The resulting tissue hypoxia may thereby induce pathological angiogenesis, which is a hallmark of disease conditions like cancer or diabetic retinopathy. However, recent evidence suggests that angiogenesis is also a major player in the context of further metabolic diseases, especially in obesity. In particular, deregulated angiogenesis is linked with adipose tissue dysfunction and insulin resistance. On the other hand, signalling pathways, such as the PI3K pathway, may regulate metabolic activities in the endothelium. Endothelial cell metabolism emerges as an important regulator of angiogenesis. This review summarises the role of angiogenesis in metabolic-vascular disease, with specific focus on the role of angiogenesis in obesity-related metabolic dysfunction and on signaling pathways, especially PI3K, linking cell metabolism to endothelial function.

You may also be interested in...

F. Stickel1 & F. Lammert2

Die Medizinische Welt 2007 58 5: 231-239

Javier Gómez-Ambrosi 1 , Javier Salvador2 , Camilo Silva2 , Carlos Pastor3 , Fernando Rotellar3 , María J. Gil4 , Javier A. Cienfuegos3 , Gema Frühbeck1,2

Thromb Haemost 2006 95 6: 991-996

A.Teetzmann, H. Koch, G. Oehler

Die Medizinische Welt 2006 57 6: 281-283